Working with mice, hamsters, and nonhuman primates, Penn researchers found that a modified version of the mRNA COVID-19 ...

Este artículo estará disponible en español en El Tiempo Latino. An abundance of evidence indicates the mRNA COVID-19 vaccines ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Despite the performance, the company expects to be at the lower end of its revenue guidance window for the year of between €2 ...

The Supreme Court hasn’t released any opinions during its current term, and none of its decisions since the pandemic match ...

For effective prevention, vaccines must stimulate mucosal immunity – an immune response in the respiratory tract where ...

With cutting-edge automation, the facility can produce mRNA material for up to 100,000 doses of a COVID-19 vaccine daily, ...

Singapore has launched Asia's first automated mRNA manufacturing facility, which will speed up vaccine production in the ...

Dr. Ashish Jha, dean of the Brown University School of Public Health and the former White House Covid-19 response coordinator ...

Anyone with COVID-19 during the summer has some, but not full, protection against germs spreading in fall and winter.

Working with animals, Penn researchers modified the mRNA vaccine to target C. difficile, an infection that kills 30,000 in ...

In the U.S., people have access to mRNA vaccines — those are the ones manufactured by Moderna and Pfizer. What makes COVID-19 ...